Articles by Andy Bender - Pharmaceutical Executive


Articles by Andy Bender

Balancing Act

The feds and states pile on layers of new regulations governing medical education. Companies interpret the rules. Here's how to manage the risk.
Sep 1, 2006

To faciliate the change process, companies must educate MSLs and reps to stay out of the grant-submission process. The new roles and job description should reflect this new regulatory landscape.

Orchestrating Compliance

Product managers are not always happy to see their compliance officers. That may be changing.
Oct 1, 2005

Product managers would be less disrupted if compliance activities at pharma companies were more anticipatory than reactionary.


Click here